These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7269853)

  • 21. Transition of drug susceptibilities of Vibrio cholerae O1 in Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Sisavath L; Munnalath K; Khampheng C; Insisiengmay S; Higa N; Kakinohana S; Iwanaga M
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):95-9. PubMed ID: 11485103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coli.
    Hof H; Rieffert M; Sticht-Groh V; Zak O; Schweizer EH
    Antimicrob Agents Chemother; 1984 Oct; 26(4):498-500. PubMed ID: 6517542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility of Campylobacter jejuni and Campylobacter fetus subsp. fetus to eight cephalosporins with special reference to species differentiation.
    Karmali MA; De Grandis S; Fleming PC
    Antimicrob Agents Chemother; 1980 Dec; 18(6):948-51. PubMed ID: 7235681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.
    Vanhoof R; Vanderlinden MP; Dierickx R; Lauwers S; Yourassowsky E; Butzler JP
    Antimicrob Agents Chemother; 1978 Oct; 14(4):553-6. PubMed ID: 718153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a metronidazole disk test for the presumptive identification of anaerobes.
    Senne JE; McCarthy LR
    Am J Med Technol; 1982 Jul; 48(7):613-6. PubMed ID: 7124785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activities of niridazole and metronidazole against anaerobic and microaerophilic bacteria.
    Hof H; Sticht-Groh V; Müller KM
    Antimicrob Agents Chemother; 1982 Aug; 22(2):332-3. PubMed ID: 6927288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The inherent characteristics and DNA polymorphism of Vibrio cholerae and other vibrios.
    Wang J; Li Y; Shi J; Li L; Bai W; Yu A; Jiang S
    Chin Med J (Engl); 2002 Apr; 115(4):589-92. PubMed ID: 12133305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic sensitivity of Campylobacter jejuni and Campylobacter coli strains with special reference to sensitivity to erythromycin and neomycin].
    Richter U; Mochmann H; Scholz H
    Padiatr Grenzgeb; 1989; 28(1):57-60. PubMed ID: 2710556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993].
    Giono-Cerezo S; Zárate A; Gutiérrez L; Valdespino JL
    Rev Latinoam Microbiol; 1994; 36(4):257-62. PubMed ID: 7701135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
    Rokosz A; Sawicka-Grzelak A; Kot K; Meszaros J; Łuczak M
    Med Dosw Mikrobiol; 2001; 53(2):167-75. PubMed ID: 11757426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of the data in the literature on the sensitivity of cholera vibrios to tetracycline].
    Semiotrochev VL; Filatov LG
    Antibiotiki; 1975 Jun; 20(7):623-8. PubMed ID: 5050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MIC test of Campylobacter jejuni/coli].
    Saku K; Sugimoto K; Uchiyama Y
    Jpn J Antibiot; 1983 Oct; 36(10):2757-62. PubMed ID: 6609250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmid content and pathogenicity of Campylobacter jejuni and Campylobacter coli strains in the pregnant guinea pig model.
    Taylor DE; Bryner JH
    Am J Vet Res; 1984 Oct; 45(10):2201-2. PubMed ID: 6497123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippurate hydrolysis by and triphenyltetrazolium tolerance of Campylobacter fetus.
    Luechtefeld NW; Wang WL
    J Clin Microbiol; 1982 Jan; 15(1):137-40. PubMed ID: 7186902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxygen requirement and tolerance of Campylobacter jejuni.
    Kaakoush NO; Miller WG; De Reuse H; Mendz GL
    Res Microbiol; 2007; 158(8-9):644-50. PubMed ID: 17890061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics.
    Butzler JP; Dekeyser P; Lafontaine T
    Antimicrob Agents Chemother; 1974 Jan; 5(1):86-9. PubMed ID: 4840451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Campylobacter, anti-aerobic, and anti-oxidative effects of roselle calyx extract and protocatechuic acid in ground beef.
    Yin MC; Chao CY
    Int J Food Microbiol; 2008 Sep; 127(1-2):73-7. PubMed ID: 18620770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial effects of niridazole: its effect on microaerophilic campylobacter.
    Hof H; Sticht-Groh V
    Infection; 1984; 12(1):36-9. PubMed ID: 6706411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incomplete anaerobiosis as a cause of metronidazole 'resistance'.
    Milne SE; Stokes EJ; Waterworth PM
    J Clin Pathol; 1978 Oct; 31(10):933-5. PubMed ID: 213449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.